PODCAST

Medical Research

ReachMD

science & medicine medicine

All Episodes

00:00:00

Gravity & the Gut: Exploring a Key Hypothesis for IBS

Medical Research ·

2023/01/31

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brennan Spiegel, MD, MSHS The pathogenesis of irritable bowel syndrome (IBS) remains unclear, but according to one professor, gravity may play a bigger role in this condition than we think. Dr. Peter Buch sits down with Dr. Brennen Spiegel from the Cedars Sinai Center for Outcomes Research and Education to dive into his research on gravitational management systems and IBS.

00:00:00

Identifying the Zebras: Key Insights on Chronic...

Medical Research ·

2023/01/31

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kyle Staller, MD, MPH Chronic abdominal pain can be caused by many things—including hereditary angioedema (HAE). Are there any barriers to diagnosing patients with HAE? Dr. Peter Buch speaks with Dr. Kyle Staller from the Gastrointestinal Motility Laboratory at Mass General to explore the differential diagnosis for HAE and share what clinicians should be on the lookout for.

00:00:00

Exploring Fungi in Cancer-Type Tumors & Cancer...

Medical Research ·

2023/01/10

Host: Mario R. Nacinovich, Jr., MSc Guest: Gregory Sepich-Poore, MD/PhD Results from a recent study detail the impact that fungi can have in human cancer tumors. What do we need to know? Mario Nacinovich speaks with one of the researchers, Dr. Gregory Sepich-Poore from UC San Diego, to dive further into these results and their impact on cancer therapeutics.

00:00:00

Our Evolving Understanding of Pain in IBD

Medical Research ·

2020/05/20

Host: Matt Birnholz, MD Guest: Emeran Mayer, MD, PhD There’s no organ in the body that has such close connections with the brain as the gut, which can often result in pain for many of our patients with IBD. Listen in as Dr. Emeran Mayer joins Dr. Matt Birnholz to explain this mind-gut connection, why patients with IBD experience pain, and how providers can manage patients who experience pain when inflammation is and isn't present.

00:00:00

2020 Crohn’s & Colitis Congress: Research Takeaways

Medical Research ·

2020/05/05

Host: Matt Birnholz, MD Guest: Maria T. Abreu, MD As emerging data supports the idea that patients with IBD can be managed by focusing on the microbiome, discussing dietary needs, and using cognitive behavioral therapy, it’s important that providers are attentive to the changing paradigms. During the 2020 Crohn’s and Colitis Foundation Congress, Dr. Maria Abreu leverages her triple-threat perspective on bench research, clinical research, and clinical care to share how we can

00:00:00

Why Has the Prevalence Rate of Autism Tripled in...

Medical Research ·

2018/07/02

Host: Paul Rokuskie Did you know that in just 10 years, the national prevalence rate for autism spectrum disorder (ASD) has nearly tripled, going from 1 in 166 to 1 in 59? Or that 2 percent of the US population under the age of 18 now carries a diagnosis of ASD? Join Paul Rokuskie as he speaks with Dr. Stuart Shapira, Associate Director for Science at CDC’s National Center on Birth Defects and Developmental Disabilities, about these and other findings from the 2018 study regarding

00:00:00

What is the Economic Impact of Autism Spectrum Disorder?

Medical Research ·

2018/07/02

Host: Paul Rokuskie Guest: David S. Mandell, ScD As prevalence rates for autism spectrum disorder (ASD) increase, so do economic costs. On average, medical expenditures for individuals with an ASD were 4 to 6 times greater than those without an ASD. Join Paul Rokuskie and his guest Dr. David Mandell, Associate Director of the Center for Autism Research at the Children’s Hospital of Philadelphia, as they dive into the economic impact of ASD.

00:00:00

Autism: The Critical Importance of Early,...

Medical Research ·

2018/06/27

Host: Paul Rokuskie As diagnostic information becomes more readily available, the importance of early diagnosis cannot be underestimated when it comes to helping those with autism spectrum disorder (ASD) and their families. Join Paul Rokuskie and his guest Dr. Stuart Shapira, Associate Director for Science at CDC’s National Center on Birth Defects and Developmental Disabilities, as they discuss the diagnosis criteria for ASD.

00:00:00

What's the Connection Between CE & Future Healthcare...

Medical Research ·

2018/03/19

Host: Alicia A. Sutton Guest: Hilary Schmidt, PhD Guest: John Ruggiero, PhD, MPA, CHCP Guest: Gregory Salinas, PhD Guest: Nili Solomonov Annually, there are around 150,000 certified activities produced in the US annually. However, meta-analyses and research estimates that less than 20% of those educational activities drive behavior change and probably less than 5% lead to improvements in patient outcomes. With a vast array of continuing education (CE) activities

00:00:00

Dr. Bennett Omalu on the Dangers of Concussions and CTE

Medical Research ·

2018/01/19

Host: Shira Johnson, MD Guest: Bennett Omalu, MD Many studies have demonstrated long-lasting and even permanent brain damage that can originate from just one concussion. With athletes suffering multiple repeated head traumas due to high-contact sports, the controversies over player safety and long-term health risks remain hot-button issues. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for chronic traumatic encephalopathy after autopsying

00:00:00

The Autopsy that Changed American Sports: Dr. Bennett...

Medical Research ·

2018/01/19

Host: Shira Johnson, MD Guest: Bennett Omalu, MD Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others who experience repetitive brain trauma. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for this condition after autopsying American football players. Host Dr. Shira Johnson welcomes Dr. Omalu to share the story of his discovery and the medical, athletic, and public responses

00:00:00

Infliximab Trough Levels at Induction to Predict...

Medical Research ·

2018/01/02

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance. Liefferinckx C1, Minsart C, Toubeau JF, Cremer A, Amininejad L, Quertinmont E, Devière J, Gils A, van Gossum A, Franchimont D. BACKGROUND: Infliximab (IFX) is indicated for the treatment of inflammatory bowel diseases (IBD). Nevertheless, loss of response (LOR) to IFX is reported in up to 10% to 30% of patients within the first year of treatment. Our objective was to evaluate the impact of the

00:00:00

RISK Cohort Study in Crohn's Disease

Medical Research ·

2017/12/15

From the 42nd Annual Renaissance Ball in Philadelphia benefiting the Crohn's & Colitis Foundation, host Lu Ann Cahn talks with Dr. David Piccoli, Chief of the Division of Gastroenterology, Hepatology and Nutrition, Director of the Biesecker PediatricLiver Center, and a board-certified pediatric gastroenterologist at Children's Hospital of Philadelphia. Dr. Piccoli discusses the RISK study, supported by the Crohn’s & Colitis Foundation, and the challenges patients face with response

00:00:00

Autism Spectrum Disorder Risk Factors: Environmental...

Medical Research ·

2017/11/17

Host: Paul Rokuskie Scientists have been doing research into many areas of autism spectrum disorder in the hopes of explaining the doubling of its prevalence rate over the past decade. Both environmental risk factors and genetic components are areas of intense scrutiny for researchers seeking to understand the root causes of autism. Host Paul Rokuskie talks with Craig Newschaffer, Professor, Associate Dean for Research, and Director of the A.J. Drexel Autism Institute, about the risk

00:00:00

Anti-TNF Treatment for Extraintestinal Manifestations...

Medical Research ·

2017/10/30

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Vavricka SR1, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N, Juillerat P, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Heinrich H, Manser CN, Safroneeva E, Raja Ali RA, Rogler G, Schoepfer AM, Greuter T; Swiss IBD Cohort Study Group. BACKGROUND: Extraintestinal manifestations (EIMs) in patients with inflammatory

00:00:00

Studies in Autism Spectrum Disorder: Paradox of...

Medical Research ·

2017/09/23

Host: Paul Rokuskie Researchers have been challenged for years by the simultaneous results of numerous studies into brain network connections in individuals with Autism Spectrum Disorder. Some results show strong connections, while others suggest the opposite. New research has helped bring some clarity to this ongoing paradox. Host Paul Rokuskie is joined by Dr. Benjamin Yerys, a child psychologist in the Center for Autism Research (CAR) at the Children’s Hospital of Philadelphia. They

00:00:00

Studies in Autism Spectrum Disorder: Paradox of...

Medical Research ·

2017/09/23

00:00:00

Immune Cells: Are They the Key to Better Allergy and...

Medical Research ·

2017/09/23

Host: Brian P. McDonough, MD, FAAFP Allergies occur when your immune system mistakes a normally harmless allergen for a dangerous invader and moves to destroy it, producing an allergic reaction. What exactly causes this response, and what are the best treatments to combat it? Host Brian McDonough chats with Dr. Avery August, Professor of Microbiology and Immunology at Cornell’s College of Veterinary Medicine, about his research regarding how allergens affect the immune system.

00:00:00

The Biophysics of Minimizing Brain Damage After...

Medical Research ·

2017/06/12

Host: Brian P. McDonough, MD, FAAFP Guest: Annalisa Scimemi Hemorrhagic strokes account for about 200,000 strokes per year. Of those who survive, about 66 percent suffer some permanent brain damage. Our guest, biophysicist Dr. Annalisa Scimemi, has been studying the receptors in the brain that may contribute to brain damage immediately after hemorrhagic stroke. Alongside host Dr. Brian McDonough, she will discuss how to lessen the effects of brain damage following a stroke.

00:00:00

Vedolizumab as Induction and Maintenance Therapy for...

Medical Research ·

2017/05/04

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy. Sands BE1, Sandborn WJ, Van Assche G, Lukas M, Xu J, James A, Abhyankar B, Lasch K. BACKGROUND: Vedolizumab is a gut-selective α4β7 integrin antagonist for the treatment of moderately to severely active Crohn's disease (CD). Aims of this study were to characterize the efficacy and safety of vedolizumab induction and maintenance therapy in

355 results

Medical Research

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事